Clinical Trials Browser

Plasmablastic Lymphoma × deltacortene × 1 year × Clear all

NCT04139304 2026-06-01

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

Phase EARLY_PHASE1 Recruiting

Plasmablastic Lymphoma